Friends Or Foes? The Changing Regulator/Industry Relationship In Europe
Top leaders discuss the evolving concept of transparency, more proactive risk management, and industry/regulator interactions at a conference marking 50 years of the EU pharmaceutical legislation.
You may also be interested in...
The Swedish head of the European Federation of Pharmaceutical Industries and Associations is moving on after five years as EFPIA director general, but will stay at the helm to help find his successor.
Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.
A “powerful new vision” for the post-Brexit UK regulatory framework was unveiled at a conference organized by the BioIndustry Association and the medicines regulator, the MHRA.